Compare BridgeBio Pharma Inc (BBIO) vs Check Point Software Technologies Ltd (CHKP) Price & Performance

BridgeBio Pharma IncTrade

Check Point Software Technologies LtdTrade

Price performance (Past 24H)

Key statistics

BridgeBio Pharma Inc vs Check Point Software Technologies Ltd — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while Check Point Software Technologies Ltd trades at $129.01 (market cap $13.18B). The key difference: BridgeBio Pharma Inc is the larger of the two by market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Check Point Software Technologies Ltd nearer its low. Which is the better fit depends on your goals.

	BBIO	CHKP
Market Cap	$16.36B	$13.18B
Sector	Health	Technology
52-Week High	$90.17	$206.91
52-Week Low	$47.29	$112.47
Enterprise Value	$18.14B	$12.88B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BBIO

BridgeBio beats Q2 estimates, confirms $1B+ 2026 sales goal and plans three product launches by 2027.Seeking Alpha · 21 hours agoBullish View details →

CHKP

Verisk Analytics CEO Lee Shavel sells 2,500 shares for $550,000.Sarah Sidlow · 4 days agoBearish View details →

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

About Check Point Software Technologies Ltd

Check Point is a global leader in cybersecurity solutions. It provides comprehensive protection against advanced cyber threats for corporate networks, cloud environments, mobile devices, and critical infrastructure.